REPL Replimune Group, Inc.
13.20USD-0.38%Mkt Cap: 1.24B $P/E: —1d ago
Replimune Group, Inc., a clinical-stage biotechnology company, focuses on the development and commercialization of oncolytic immunotherapies to treat cancer in the United States and the United Kingdom. The company's prop…
Industry Peers
Biotechnology$128.08BUSDP/E 29.4
$78.44BUSD
$76.40BUSDP/E 18.4
$57.03BUSDP/E 37.3
$58.08BUSDP/E 35.4
$42.24BUSDP/E 18.0
$43.05BUSD
$41.41BUSDP/E 65.1
$32.80BUSDP/E 30.2
$30.03BUSDP/E 37.8
$25.10BUSD
$23.93BUSD
$22.99BUSDP/E 14.5
$22.27BUSDP/E 30.7
$22.54BUSDP/E 28.9
$22.22BUSD
$15.03BUSDP/E 17.5
$15.01BUSDP/E 15.8
$14.48BUSDP/E 18.4
$14.32BUSD
Key Statistics
Company
Market Cap1.24B USD
Enterprise Value1.17B USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-313.94M USD
Revenue/Share—
Last Price13.20 USD
Fiscal Year EndMar 2026
MR QuarterJun 2026
Employees465
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-6.50
PEG—
EV/EBITDA-4.01
EV/Revenue—
P/S—
P/B10.53
EPS (TTM)-3.17
EPS (Forward)-2.04
52W Range
1.50079% of range16.33
52W High16.33 USD
52W Low1.500 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-188.94%
ROA-94.45%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-280.34M USD
CapEx (TTM)4.22M USD
FCF Margin—
FCF Yield-13.80%
Net Debt-83.35M USD
Net Debt/EBITDA0.29
Balance Sheet
Debt/Equity0.67
Current Ratio5.23
Quick Ratio5.08
Book Value/Sh1.26 USD
Cash/Share2.07 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.8 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)19.50 USD
Upside (mean)+47.7%
Target Range14.00 USD – 24.00 USD
14.00+47.7% to mean24.00
# Analysts6
Ownership
Shares Out.94.22M
Float67.65M
Insiders1.65%
Institutions105.77%
Short Interest
Short Ratio9.4d
Short % Float33.69%
Short % Out.24.15%
Shares Short22.75M
Short (prev mo.)24.87M
Technical
SMA 5013.22 (-0.2%)
SMA 2008.927 (+47.9%)
Beta0.94
S&P 52W Chg16.45%
Avg Vol (30d)2.31M
Avg Vol (10d)2.32M
Technical Indicators
RSI (14)49.6
MACD-0.0520
MACD Signal0.0025
MACD Hist.-0.0546
BB Upper14.68 USD
BB Middle13.30 USD
BB Lower11.91 USD
BB Width20.81%
ATR (14)0.8661 USD
Vol Ratio (20d)0.74x